Rockwell Medical

RMTI

Market cap $41M

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2025 on Wednesday, November 12, 2025.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Heather Hunter was promoted to Chief Operating Officer, having previously served as Chief Corporate Affairs Officer since August 2022.

Rockwell Medical (RMTI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Rockwell Medical (RMTI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Image source: The Motley Fool.

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q2 2025 Earnings Conference Call August 14, 2025 8:00 AM ET Company Participants Heather H. Hunter - Senior VP & Chief Corporate Affairs Officer Jesse Neri - Senior VP & CFO Mark Strobeck - President, CEO & Director Conference Call Participants Jeremy Pearlman - Maxim Group LLC, Research Division Raghuram Selvaraju - H.C.

Rockwell Medical (RMTI) came out with a quarterly loss of $0.05 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.01 per share a year ago.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces financial and operational results for the three and six months ended June 30, 2025.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025.